Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Myeloma · Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Anhui Provincial Hospital, Hefei, Anhui, China

    Contact: Study coordinator (Zimin Sun)
    Contact: Principal Investigator (Zimin Sun)
  • Peking University Third Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Hongmei Jing)
    Contact: Principal Investigator (Hongmei Jing)
  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Baijun Fang)
    Contact: Principal Investigator (Baijun Fang)
  • Shandong Cancer Hospital, Jinan, Shandong, China

    Contact: Study coordinator (Zengjun Li)
    Contact: Principal Investigator (Zengjun Li)
  • Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Wei Liu, MD) · liuwei@ihcams.ac.cn · 86-022-23909282
    Contact: Principal Investigator (Lugui Qiu, MD)
  • Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Yafei Wang)
    Contact: Principal Investigator (Yafei Wang)
  • Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Rong Fu)
    Contact: Principal Investigator (Rong Fu)